Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 1
1962 1
1963 1
1968 2
1970 2
1971 4
1972 2
1973 2
1974 1
1976 1
1977 2
1978 2
1979 5
1980 4
1981 2
1983 2
1984 3
1985 3
1986 9
1987 12
1988 8
1989 13
1990 21
1991 34
1992 27
1993 25
1994 36
1995 32
1996 45
1997 46
1998 65
1999 61
2000 102
2001 121
2002 122
2003 171
2004 226
2005 274
2006 341
2007 364
2008 417
2009 506
2010 614
2011 668
2012 827
2013 809
2014 917
2015 984
2016 966
2017 976
2018 1089
2019 1153
2020 1252
2021 620
Text availability
Article attribute
Article type
Publication date

Search Results

12,431 results
Results by year
Filters applied: . Clear all
Page 1
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation.
Dhillon P, Park J, Hurtado Del Pozo C, Li L, Doke T, Huang S, Zhao J, Kang HM, Shrestra R, Balzer MS, Chatterjee S, Prado P, Han SY, Liu H, Sheng X, Dierickx P, Batmanov K, Romero JP, Prósper F, Li M, Pei L, Kim J, Montserrat N, Susztak K. Dhillon P, et al. Among authors: kang hm. Cell Metab. 2021 Feb 2;33(2):379-394.e8. doi: 10.1016/j.cmet.2020.11.011. Epub 2020 Dec 9. Cell Metab. 2021. PMID: 33301705
Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease.
Nielsen JB, Rom O, Surakka I, Graham SE, Zhou W, Roychowdhury T, Fritsche LG, Gagliano Taliun SA, Sidore C, Liu Y, Gabrielsen ME, Skogholt AH, Wolford B, Overton W, Zhao Y, Chen J, Zhang H, Hornsby WE, Acheampong A, Grooms A, Schaefer A, Zajac GJM, Villacorta L, Zhang J, Brumpton B, Løset M, Rai V, Lundegaard PR, Olesen MS, Taylor KD, Palmer ND, Chen YD, Choi SH, Lubitz SA, Ellinor PT, Barnes KC, Daya M, Rafaels N, Weiss ST, Lasky-Su J, Tracy RP, Vasan RS, Cupples LA, Mathias RA, Yanek LR, Becker LC, Peyser PA, Bielak LF, Smith JA, Aslibekyan S, Hidalgo BA, Arnett DK, Irvin MR, Wilson JG, Musani SK, Correa A, Rich SS, Guo X, Rotter JI, Konkle BA, Johnsen JM, Ashley-Koch AE, Telen MJ, Sheehan VA, Blangero J, Curran JE, Peralta JM, Montgomery C, Sheu WH, Chung RH, Schwander K, Nouraie SM, Gordeuk VR, Zhang Y, Kooperberg C, Reiner AP, Jackson RD, Bleecker ER, Meyers DA, Li X, Das S, Yu K, LeFaive J, Smith A, Blackwell T, Taliun D, Zollner S, Forer L, Schoenherr S, Fuchsberger C, Pandit A, Zawistowski M, Kheterpal S, Brummett CM, Natarajan P, Schlessinger D, Lee S, Kang HM, Cucca F, Holmen OL, Åsvold BO, Boehnke M, Kathiresan S, Abecasis GR, Chen YE, Willer CJ, Hveem K. Nielsen JB, et al. Among authors: kang hm. Nat Commun. 2020 Dec 18;11(1):6417. doi: 10.1038/s41467-020-20086-3. Nat Commun. 2020. PMID: 33339817 Free PMC article.
Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z, Zheng Y, Yao J, Liu Y, Ruan J, Deng Y, Zhou L, Zhao P, Yang S, Hu J, We B, Wu Y, Zhang D, Kang H, Dai Z. Zhai Z, et al. Among authors: kang h. JAMA Netw Open. 2020 Nov 2;3(11):e2021881. doi: 10.1001/jamanetworkopen.2020.21881. JAMA Netw Open. 2020. PMID: 33211105 Free PMC article.
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Ariceta G, Dixon BP, Kim SH, Kapur G, Mauch T, Ortiz S, Vallee M, Denker AE, Kang HG, Greenbaum LA; 312 Study Group. Ariceta G, et al. Among authors: kang hg. Kidney Int. 2020 Dec 8:S0085-2538(20)31418-6. doi: 10.1016/j.kint.2020.10.046. Online ahead of print. Kidney Int. 2020. PMID: 33307104 Free article.
Tumor heterogeneity in muscle-invasive bladder cancer.
Kang HW, Kim WJ, Choi W, Yun SJ. Kang HW, et al. Transl Androl Urol. 2020 Dec;9(6):2866-2880. doi: 10.21037/tau.2020.03.13. Transl Androl Urol. 2020. PMID: 33457261 Free PMC article. Review.
12,431 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page